Clare Fasching

Clare Fasching is a seasoned professional in the field of assay development and molecular diagnostics with extensive experience across various leadership roles. Currently serving as the Director of Assay Development at Melio since May 2023, Clare previously held the position of Associate Director of Clinical and Assay R&D at Mammoth Biosciences, where notable contributions included optimizing CRISPR-based diagnostic assays and leading interdisciplinary teams. Academic credentials encompass a Ph.D. in Cellular and Molecular Biology from the University of Sydney and advanced degrees from California State University, Long Beach, and Colorado State University. Clare's career spans various organizations, including significant roles at Telomere Diagnostics, SageMedic, and UC Davis, showcasing expertise in molecular diagnostic methods, assay integration, and cancer biology. Additionally, Clare's advisory role at the CLSI California Life Sciences Institute highlights involvement in supporting emerging diagnostic and therapeutic companies.